Related News

No related news articles were found.

nutraceutical intl corp (NU2) Related Businessweek News

No Related Businessweek News Found

nutraceutical intl corp (NU2) Details

Nutraceutical International Corporation manufactures, markets, distributes, and retails branded nutritional supplements and other natural products in the United States and internationally. It offers vitamins and minerals, herbs, specialty formulas, personal care products, homeopathics, functional foods, and other products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, creams, sprays, powders, and whole herbs. The company sells its products under the Solaray, KAL, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store, and Monarch Nutraceuticals brands. It also owns neighborhood natural food markets, which operate under the trade names of The Real Food Company, Thom's Natural Foods, and Cornucopia Community Market; and health food stores under various trade names, including Fresh Vitamins, Granola's, and Peachtree Natural Foods. The company sells its products primarily to and through health and natural food stores in the United States, as well as through retailers and distributors, and others directly to consumers. Nutraceutical International Corporation was founded in 1993 and is based in Park City, Utah.

nutraceutical intl corp (NU2) Key Developments

Nutraceutical International Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015

Jul 30 15

Nutraceutical International Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2015. For the quarter, the company reported net sales of $54,382,000 compared to $55,625,000 a year ago. Income from operations was $6,637,000 compared to $6,686,000 a year ago. Income before provision for income taxes was $6,380,000 compared to $6,330,000 a year ago. Net income was $4,450,000 or $0.47 per basic and diluted common share compared to $3,997,000 or $0.41 per basic and diluted common share a year ago. Adjusted EBITDA was $9,832,000 compared to $9,628,000 a year ago. The decrease in fiscal 2015 third quarter net sales of 2.2% was primarily related to international customers and, to a lesser extent, private label accounts.
For the nine months, the company reported net sales of $162,830,000 compared to $162,034,000 a year ago. Income from operations was $18,944,000 compared to $20,809,000 a year ago. Income before provision for income taxes was $18,117,000 compared to $19,785,000 a year ago. Net income was $11,897,000 or $1.24 per diluted common share compared to $12,456,000 or $1.27 per diluted common share a year ago. Adjusted EBITDA was $28,646,000 compared to $29,166,000 a year ago. Operating cash flow was $21.2 million compared to $16.1 million for the same period of fiscal 2014. The operating cash flow for the nine months ended June 30, 2015, combined with existing cash, was primarily used to repay net borrowings of $11.0 million on the company's revolving credit facility and to invest $6.5 million in purchases of property, plant and equipment, $3.6 million in purchases of common stock for treasury and $1.3 million in acquisitions of natural product businesses.

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2015

Apr 30 15

Nutraceutical International Corporation reported unaudited consolidated earnings results for the second quarter and six months ended March 31, 2015. Net sales for the fiscal 2015 second quarter were $55.4 million compared to $54.9 million for the same quarter of fiscal 2014. For the second quarter of fiscal 2015, net income was $4.1 million, or $0.43 diluted earnings per share, compared to net income of $4.3 million, or $0.44 diluted earnings per share, for the same quarter of fiscal 2014. Income from operations was $6.738 million against $7.226 million a year ago. Income before provision for income taxes was $6.465 million against $6.876 million a year ago. Adjusted EBITDA was $10.006 million against $10.003 million a year ago.
Net sales for the six months ended March 31, 2015 were $108.4 million compared to $106.4 million for the same period of fiscal 2014. For the six months ended March 31, 2015, net income was $7.4 million, or $0.77 diluted earnings per share, compared to net income of $8.5 million, or $0.86 diluted earnings per share, for the same period of fiscal 2014. Operating cash flow for the six months ended March 31, 2015 was $11.2 million compared to $10.8 million for the same period of fiscal 2014. The operating cash flow for the six months ended March 31, 2015, combined with existing cash, was primarily used to invest $4.2 million in purchases of property, plant and equipment, $2.4 million in purchases of common stock for treasury and to repay net borrowings of $5.0 million on the Company's revolving credit facility. Income from operations was $12.307 million against $14.123 million a year ago. Adjusted EBITDA was $18.814 million against $19.538 million a year ago.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.